![]() |
市場調查報告書
商品編碼
1395094
動物血液和血液成分市場 - 副產品(全血、紅血球、白血球、血小板、血漿)、動物(大型、小型)、應用(出血、手術、癌症治療、出血性疾病)、最終用戶(醫院、血庫) ) , 2023 年全球預測Animal Blood & Blood Components Market - By Product (Whole Blood, RBC, WBC, Platelet, Plasma), Animal (Large, Small), Application (Hemorrhage, Surgery, Cancer Treatment, Bleeding Disorders), End-User (Hospital, Blood Bank), Global Forecast 2023 |
由於寵物主人擴大為他們的動物尋求全面的醫療保健服務,包括手術、治療和療法,預計動物血液和血液成分市場在 2023 年和 2032 年的CAGR將超過 9.7%。
動物的傳染病和慢性疾病增加,可能需要輸血來支持治療方案。根據世界衛生組織 2023 年發布的報告,全球報告的新興傳染病中約 60% 源自動物,涵蓋野生和家養物種。在過去的三十年裡,已經發現了 30 多種新的人類病原體,其中 75% 來自動物。該組織的「同一個健康」計劃專注於透過整合而不是分離這些系統來最佳化動物、人類和生態系統的健康。此類措施將刺激產品需求。
整個動物血液和血液成分市場根據產品、動物類型、應用、最終用戶和地區進行分類。
血漿產品領域預計在 2023 年和 2032 年將顯著成長,因為它富含凝血因子和抗體等必需成分。動物疾病盛行率不斷上升,需要利用血漿衍生療法。這在緊急情況下尤其明顯,因為緊急情況的重點是有效滿足醫療保健需求。
動物血液和血液成分產業的癌症治療應用預計到 2032 年將產生高收入。隨著動物癌症診斷變得越來越普遍,對包括化療和放射治療在內的專門治療的需求不斷增加。動物血液和血液成分含有重要元素,在支持這些干預措施方面發揮著至關重要的作用,有助於加強護理和改善結果。
在旨在提高動物保健標準的政府舉措和專業獸醫服務興起的支持下,亞太地區動物血液和血液成分市場將在 2023 年至 2032 年呈現令人印象深刻的成長趨勢。該地區動物種群多樣化,包括伴侶動物和牲畜,擴大了對各種血液製品的需求。創新獸醫技術的採用以及對動物輸血益處的日益認知將在未來幾年繼續影響亞太地區的市場動態。
Animal Blood & Blood Components Market is estimated to register a CAGR of over 9.7% during 2023 and 2032, as pet owners are increasingly seeking comprehensive healthcare services for their animals, including surgeries, treatments, and therapies.
There is a rise in infectious and chronic diseases among animals which may require blood transfusions to support treatment protocols. According to a report by World Health Organization published in 2023, approximately 60% of globally reported emerging infectious diseases stem from animals, spanning both wild and domestic species. Within the past three decades, over 30 new human pathogens have been identified, with 75% of these originating from animal sources. The One Health program by the organization focuses on optimizing the health of animals, humans, and ecosystems by integrating these systems, rather than separating them. Such initiative will boost the product demand.
The overall animal blood & blood components market is classified based on product, animal type, application, end-user, and region.
Plasma product segment is poised for a notable growth during 2023 and 2032, as it is rich in essential components such as clotting factors and antibodies. The rising prevalence of diseases in animals necessitates the utilization of plasma-derived therapies. This is particularly evident in emergency situations where the focus in on efficiently meeting the healthcare needs.
Cancer treatment application of animal blood & blood components industry is anticipated to generate high revenues by 2032. As cancer diagnoses in animals become more prevalent, there is an escalating demand for specialized treatments, including chemotherapy and radiation therapy. Animal blood and blood components, having vital elements, play a crucial role in supporting these interventions, contributing to enhanced care and improved outcomes.
Asia Pacific animal blood and blood components market will showcase impressive growth trends over 2023-2032, backed by the governmental initiatives aimed at enhancing animal healthcare standards and the rise of specialized veterinary services. The diverse animal population across the region, encompassing both companion animals and livestock, amplifies the demand for a wide range of blood products. Adoption of innovative veterinary technologies and a burgeoning awareness of the benefits associated with animal blood transfusions will continue to shape the market dynamics in the APAC region in the coming years.